How to De-Risk and Make Your Proton Therapy Project Successful
In this panel discussion, Dr. Steven Frank exchanges views on the best ways to de-risk your proton therapy project with five experts from the proton therapy...
In this panel discussion, Dr. Steven Frank exchanges views on the best ways to de-risk your proton therapy project with five experts from the proton therapy...
Proton therapy was more likely to be cost-effective for patients with p16-positive tumors ($234,201/QALY), compared to p16-negative tumors ($516,297/QALY). For...